JPMorgan Diversified Return International Eqty ETF vs Relay Therapeutics Inc. Common Stock — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $73.01 (market cap $378.77M), while Relay Therapeutics Inc. Common Stock trades at $18.14 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 10.1× JPMorgan Diversified Return International Eqty ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, JPMorgan Diversified Return International Eqty ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Diversified Return International Eqty ETF for 120 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| JPIN | RLAY | |
|---|---|---|
Market Cap | $378.77M | $3.82B |
Volume | 13,861 | 4,332,079 |
52-Week High | $77.80 | $20.75 |
52-Week Low | $64.96 | $6.03 |
Typical Hold Time | 120 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $2.93B |
Signals from Pluang's Aura AI — not financial advice
JPIN trades at $73.01, showing minimal daily movement with a 0.1% gain. Technical indicators are predominantly bearish, with moving averages and oscillators signaling selling pressure, though RSI levels suggest potential oversold conditions. The ETF, designed for international equity exposure, lacks current fundamental data for valuation ratios and profitability metrics.
The outlook remains cautious due to strong bearish technical signals and absence of recent financial updates. Key risks include market volatility and reliance on international equities. Investors should await earnings reports for fundamental clarity, as current data is insufficient to assess valuation or growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →